Canadian Conference on Ovarian Cancer Research

Co-Chairs:

Jeanette Boudreau, PhD, Dalhousie University
Katharina Kieser, MD, Dalhousie University
Tania Vrionis, CEO, Ovarian Cancer Canada

Members:

Dr. Lauren Adolph, MD, Dalhousie University
Ms. Morgan Pugh-Toole, MSc, Dalhousie University
Dr. Francis Rodier, PhD, Université de Montréal
Dr. Alicia Tone, PhD, Ovarian Cancer Canada
Dr. Robin Urquhart, PhD, Dalhousie University
Dr. Karla Willows, MD, Dalhousie University and Nova Scotia Health Authority

Dr. Dimcho Bachvarov, PhD, Université Laval, CHU-Q, Centre de recherche, Hôtel-Dieu de Québec
Mrs. Elisabeth Baugh, Former CEO, Ovarian Cancer Canada and Honorary Co-chair
Dr. Theodore Brown, PhD, Lunenfeld-Tanenbaum Research Institute and University of Toronto
Dr. Walter Gotlieb, MD, PhD, McGill University, SMPD Jewish General Hospital
Dr. Hal Hirte, MD, Juravinski Cancer Centre
Dr. David G. Huntsman, MD, University of British Columbia
Dr. Helen Mackay, MD, Division of Hematology/Oncology, UHN, Princess Margaret Hospital
Dr. Jessica McAlpine, MD, University of British Columbia, BC Cancer Agency
Dr. Anne-Marie Mes-Masson, PhD, Université de Montréal
Dr. Dianne Miller, MD, Reproductive Endocrinology & Infertility, BC Women’s Hospital
Dr. Brad Nelson, PhD, BC Cancer Agency
Dr. Marie Plante, MD, PhD, Université Laval, CHU-Q, Centre de recherche, Hôtel-Dieu de Québec
Dr. Lynn Postovit, PhD, Cancer Research Institute of Northern Alberta, University of Alberta
Dr. Trevor Shepherd, PhD, The University of Western Ontario
Dr. Helen Steed, MD, PhD, University of Alberta
Dr. Barbara Vanderhyden, PhD, University of Ottawa

Registered delegates wishing to cancel attendance at the 11th Canadian Conference on Ovarian Cancer Research, including those whose abstracts have not been selected for presentation, must provide a written request for their refund on or before April 15, 2024. A $25 cancellation fee applies. The 11th CCOCR regrets that requests received after this date will not be considered. All approved refunds will be issued after the Conference.
Attendees must submit a request to cancel in writing via email to info@iseventsolutions.com by April 15, 2024 to receive a refund.

Include the following in your request:

1. Full name
2. Amount of refund requested
3. Reason(s) for request
4. Copy of any document necessitating your inability to participate (examples include airline flight cancellation confirmation, government order to not travel, employer order to not travel).

The Canadian Conference on Ovarian Cancer Research welcomes all patients and caregivers, trainees, researchers, clinicians, affiliated health professionals, and industry partners engaged in ovarian cancer research. Participants are expected to engage in productive, respectful and constructive discussion, aimed at interpretable and high impact science. Debate of ideas is encouraged, allowing delegates to enjoy a lively and stimulating conference, but personal attacks, discriminatory, racist or otherwise exclusionary discourse will not be tolerated and delegates engaging in such behaviour will be asked to leave the conference without an opportunity for registration refunds or expense reimbursement.

We encourage the use of social media before, during, and after the conference to share information and to network with others. However, we ask all conference participants to adhere to the following social media guidelines:

• Blog or tweet about what you are hearing and learning, but refrain from sharing unpublished data or any photos or information as requested by the speaker verbally or on their slides. Talks are tweetable and shareable by default, but speakers can request that specific details or slides not be shared.
• Whenever possible, use the hashtag #ccocr2024 to discuss the conference.
• Provide feedback to the conference committees. We encourage participants to post and discuss topics of interest as well as ideas for future meetings.
• Communicate with respect and consideration for others, keeping criticism constructive.
• Do not engage in rudeness or personal attacks.

The 11^th Canadian Conference on Ovarian Cancer Research is committed to inclusivity. Within our invited speakers and delegate groups, we welcome diversity, including those who identify as minorities, including, but not limited to those with diverse racial and geographical background, sex and gender identities, socioeconomic, educational, religious or other beliefs and abilities. Demographic information will be collected at registration on a voluntary basis; this will be kept in confidence and used only for the purposes of tracking our progress toward achieving diversity.